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In the thymus four lymphoid subsets are identified by CD4 and CD8 antigen
expression (1, 2). CD4,CD8- cells are precursors for all other thymocyte popu-
lations (3, 4), which include CD4'',CD8- and CD4-,CD8 medullary subsets that
are similar to mature T lymphocytes and contain immunocompetent cells (5-7).
Most thymocytes are found in the cortex and are CD4''',CD8'. However, these
cells have no known function and most of them appear destined for intrathymic
death (2, 6, 7).
Rat thymic cells can be further subdivided by expression of the MRC OX-44
antigen (M,. 43,000), which is found on all mature T cells, macrophages, and
other leucocytes, but only on 10-15% of thymocytes (8). The OX-44' cells
include all those with thymopoietic activity or the ability to respond to alloanti-
gens or lectins. Most ofthe OX-44- cells are CD4+,CD8' cortical cells, but there
are also OX-44- subpopulations in the CD4+,CD8- and CD4-,CD8+ sets. In the
present study we have established that cells with the CD4-,CD8'',OX-44- phe-
notype constitute an early stage in thymopoiesis, whilst CD4+,CD8-,OX-44- cells
do not have these properties.
Materials and Methods
All antibodies and methodsare described in references 8 and 9.
Results
BriefDefinitive Report
Identification of a Transient Cortical Thymocyte Population.
￿
Cell populations
were studied during thymic regeneration in animals given 3 Gy whole-body
gamma irradiation. This dose kills cortical but not medullary thymocytes and
most dead cells are phagocytosed by macrophages within 48 h ofirradiation (10
and Paterson, D., unpublished results). Small numbers of dividing cells were
detected in the cortex by bromodeoxyuridine (BUdR) labeling on day 2 after
irradiation (not shown), and dividing cortical cells were abundant on days 3 and
4 (Fig. 1, b and c). For comparison, BUdR-labeled cells in a normal thymus are
shown in Fig. 1 a . Most cortical cells appearing at day 3 and day 3.5 lacked CD4
antigen expression (Fig. 1 e) but were positive for CD8 antigen expression (Fig.
If). Also, many of the cortical cells were OX-44- (Fig. 1g), although this was
less clear than for CD4 labeling. OX-44' thymocytes include CD4-,CD8- cells
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TABLE I
Proportion ofDividing Cells in Thymocyte Subsets
Animals were injected intravenously with BUdR at 10 mg/kg body weight I h before they were killed. Thymocyte
subpopulations were prepared by rosette depletion at 4°C (Exps. 1-7) orby cell sorting (Exp. 8), and weresmeared
and labeled with an anti-BUdR antibody (Bu-20a) using the immunoperoxidase technique. BUdR* cells were
estimated by scoring 1,000 cells from each of three slides and taking the mean count. Depleted populations were
93-98% pure, except for Exp. 1 where populations were 84% pure. Numbers in parentheses indicate the percent
of total thymocytes that the subsets represent (reference 8). Exps. 5, 7, and 8 used PVG rats, the rest used AO rats.
as well as mature phenotype cells and the CD4-,CD8- cells are probably located
in the cortex. By day 4 the pattern had changed to most cortical cells showing
the normal CD4+,CD8+,OX-44- cortical thymocyte phenotype, although quan-
titatively CD4 expression did not attain normal levels until day 5 after irradiation
(data not shown). Thus a cell type probably of CD4-,CD8+,OX-44- phenotype
had matured to the CD4+,CD8+,OX-44- type in cortical regeneration, since it
seems unlikely that cell migration could account for thecortical changes between
days 3.5 and 4.
Cell Division within Subsets from Normal Thymus.
￿
CD4-,CD8+,OX-44- cells
constitute only ^-2% of normal thymus, but if these cells are an intermediate
population then a high proportion ofcycling cells may be found within this set.
This was analyzed by BUdR labeling of thymocytes in vivo (see Table I). The
CD4-,CD8+,OX-44- set contained 31-51% BUd' cells. In sharp contrast was
the finding that only ^-2% of CD4'',CD8-,OX-44- cells were BUdR'}, while 4-
7% of CD4-,CD8-,OX-44+ cells were positive, which is similar to the value for
unfractionated thymocytes (Table I). This suggests that most CD4-,CD8-,OX-
44' cells are in the resting phase.
Although CD4-,CD8+,OX-44- cells show a high percent of BUdR+ cells, this
set accounts for only -1% of the 7% of labeled cells in the unfractionated
population. It seems likely that most BUdR+ cells are CD4+,CD8'',OX-44- since
most labeled cells are located in the cortex (Fig. 1a), and when OX-44- cells
were isolated, the percent ofBUd' cells was similar to that for unfractionated
cells (Table I and reference 8).
FIGURE 1 .
￿
mAb labeling of regenerating thymus. AO rats were given 3 Gy irradiation and
then killed at timed intervals. Cryostat sections (5 ltm) were stained usingthe immunoperoxi-
dase technique. (a-d) Animals were injected intravenously with 10 mg/kgbody weight BUdR
1 h before they were killed. (a) Normal thymus labeled with Bu20a (anti-BUdR mAb): (m)
medulla, (c) cortex. (b and c) Day 3 and 4 after irradiation; Bu20a mAb. (d) Day 4; OX-21
(control mAb). (e-h) High magnification views ofthe cortex, wheresections from day 3.5 after
irradiation are labeled with (e) CD4, (f) CD8, (g) OX-44, and (h) OX-21 mAbs. Arrows
indicate macrophages stained with CD4or OX-44mAbs. This assignment is made becauserat
macrophages are CD4',OX-44+ and use of macrophage-specific mAbs on other sections
identified labeled cells with themorphology of those arrowedabove. (a-d) Bar represents 83
lam; (e-h) 28 lam.
Thymocyte
subset 1 2
Percent
3
dividing cells
4
for
5
experiment:
6 7 8
Unfractionated (100%) 7.2 6.5 9.3 6.7 6.4 6.5 5.9 6.1
CD4-CD8*OX-44- (2%) 31.0 - 50.8 32.5 47.7 45.7 - -
CD4*CD8-OX-44- (2%) 1.1 - - 1 .9 - - - -
CD4-CD8-OX-44' (I - 7.0 - - - - 3.7 -
-2%)
OX-44- (88%) - - - - - - - 4.6
OX-44` (12%) - - - - - - - 2.21606
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FIGURE 2.
￿
Analysis of AO thymocyte subsets on the FACS. (b and d) Populations were
prepared by rosette depletion. (a-c) one experiment where the phenotype of CD4-,OX-44-
thymocytes before (b)andafter 18 h in culture (c)is compared with unfractionated thymocytes
(a). Control profiles: OX-21 (a); CD4 + ,OX-44 (b); OX-21 (c); CD4 + CD8 (d) are superim-
posed. (a-c)Cells were analyzed on the same scatterand fluorescence gains.
FACS Analysis of CD4-,OX-44- and CD4-,CD8- Cells.
￿
Forward light scatter
analysis shows that CD4-,OX-44- thymocytes are a heterogeneous population of
mostly medium and large cells (Fig. 2b). These cells all express CD8 antigen at
a level similar to that of unfractionated thymocytes (Fig. 2, a and b), and they
also show clear expression of MHC class I antigen. They do not express any
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detectable IL-2-R, and little, if any, transferrin receptor (OX-26 labeling) (Fig.
2 b).
CD4-,CD8- thymocytes are also a heterogeneous population of mainly medium
and large cells (Fig. 2 d). These cells all clearly express both MHC class I and
OX-44 antigens but lack IL-2-R and transferrin receptor expression. Labeling
of IL-2-R was with the OX-39 mAb (9) and the negative result was confirmed
with a second noncompetitive anti-IL-2-R mAb provided by Dr. M . Dallman.
In Vitro Differentiation ofCD4-,CD8+,OX-44- Thymocytes.
￿
CD4-,CD8+,OX-44-
thymocytes prepared by rosette depletion were cultured at 3-5 X 106 cells/ ml
in RPMI/10% FCS for 18 h in the absence of accessory cells. A 7-13% increase
in cell number (37% in one case) occurred during the culture period, with
recovered cells being 60-88% viable. Viable cells were purified using an Isopaque
Ficoll gradient and were then labeled for FACS analysis. Cultured cells were
mostly medium sized . Virtually all expressed the CD4 antigen, with most cells as
bright as unfractionated thymocytes (Fig. 2, a and c). This was clearly seen in six
experiments. Cultured cells remained CD8+,OX-44-, showed an increase in
transferrin receptor expression (OX-26), and showed a decrease in MHC class I
expression (Fig. 2, compare c and b). IL-2-R expression of these cells has not
been studied. Hence, upon in vitro culture, CD4-,CD8+,OX-44- thymocytes
express a CD4+,CD8+,OX-44' phenotype; this parallels the phenotypic change
seen during thymus regeneration after irradiation .
Discussion
The CD4-,CD8+,OX-44- thymocyte subset has been clearly shown to give rise
to cells of CD4+,CD8+,OX-44- cortical phenotype in vitro, and the same changes
appeared to occur in vivo in thymic regeneration. It seems possible that
CD4-,CD8+,OX-44- cells are derived directly from CD4-,CD8-,OX-44+ cells.
This lineage would be in accord with data on thymic ontogeny in mouse and
sheep where CD8 antigen expression preceded that of CD4 antigen (11, 12).
Also in the mouse, the CD4-,CD8+ cells can be split into two sets by expression
of the J 11d antigen (13). All immunocompetent cells are J 11d- and the
CD4-,CD8+,Jl Id' set may be the mouse equivalent of rat CD4-,CD8+,OX-44-
cells.
An outstanding problem is now to determine the origin of the CD4-,CD8+,OX-
44+ and CD4+,CD8-,OX-44+ cells that are immunocompetent and found in the
medulla. We had previously suggested (8) that loss of the OX-44 antigen may
mark the entry of cells into the pathway that results in cell death, but this would
not be in accord with an important intermediate role for CD4- ,CD8+,OX-44-
cells. A key question is whether the medullary cells are rescued from a dead-end
pathway by positive selection from CD4-,CD8+,OX-44- or CD4+,CD8+,OX-44-
cells, and it may be possible to resolve this by determining the progeny of cells
after injection into thymuses cultured in vitro (3). Determination of whether
TCR chains are expressed in the CD4-,CD8+,OX-44- cells will also be essential.
One interesting additional point resulting from this study is the finding that
most CD4-,CD8- cells lack detectable IL-2-R expression. In the mouse, ^"50%
of CD4-,CD8- cells express IL-2-R, but the absence of IL-2-R from the equiva-1608
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lent rat cells adds to the doubt about the functional role of these receptors in
early thymic differentiation (14).
Summary
Thymocytes of CD4-,CD8+,OX-44- phenotype have been shown to be an
intermediate of thymopoiesis that give rise to cellsof CD4+,CD8+,OX-44- normal
cortical thymocyte phenotype both in vitro and in vivo during thymic regenera-
tion.
Receivedfor publication 3 August 1987.
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